JB Chemicals & Pharmaceuticals has informed that the compensation committee of the board of directors of the company has, on September 10, 2015, issued and allotted 1,025 equity shares of face value of Rs 2 each (1,025 shares at a premium of Rs 93 per share) to certain employees against the exercise of options granted to them pursuant to Employees Stock Option Scheme of the company. The issued and paid up capital has thus gone up from 8,48,18,950 equity shares of Rs 2 each to 8,48,19,975 equity shares of Rs 2 each.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: